Coya Therapeutics, Inc. Quarterly Debt-to-equity in % from Q3 2023 to Q2 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Coya Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2023 to Q2 2025.
Coya Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2025 was 13.9 %, a 8.08% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2025	13.9	-1.22	-8.08%	Jun 30, 2025
Q1 2025	12.9	-2.09	-14%	Mar 31, 2025
Q4 2024	12.9	-0.28	-2.12%	Dec 31, 2024
Q3 2024	13.9	-53.9	-79.5%	Sep 30, 2024
Q2 2024	15.1			Jun 30, 2024
Q1 2024	15			Mar 31, 2024
Q4 2023	13.2			Dec 31, 2023
Q3 2023	67.8			Sep 30, 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.